MENU

Expert Voices in Dementia

Expert Voices in Dementia Art

Alzheimer Disease & Dementia

01.25.25

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Timo Grimmer, MD

Timo Grimmer, MD, Associate Professor of Psychiatry and Psychotherapy and Head of the Centre for Cognitive Disorders at the Technical University of Munich, Germany, discusses the experimental oral small molecule drug blarcamesine, which is under investigation as a potential treatment for Alzheimer disease.

More Alzheimer Disease & Dementia Podcasts

Dilemmas in Dementia Art

Dilemmas in Dementia

Explore real-world challenges in dementia practice and strategies to help address these issues. Topics discussed include comorbidities, limited resources and therapeutic options, and an unpredictable clinical course.
Dementia Dialogues art

Dementia Dialogues

Explore real-world challenges in dementia practice and strategies to help address these issues. Topics discussed include comorbidities, limited resources and therapeutic options, and an unpredictable clinical course.

Subscribe to Updates

Sign up to receive alerts and updates from The Neurology Hub.

Thanks for subscribing

CALL FOR CONTRIBUTORS

Do you have cases, images, or other information to share? The Neurology Hub welcomes submissions from clinicians and researchers at all levels.

Contribute Here

More in Alzeheimer DISEASE and Dementia

Caregiver Essentials Dementia Challenges Evaluation & Diagnosis Treatments & Therapies

Subscribe to Updates

Sign up to receive alerts and updates from The Neurology Hub.

Thanks for subscribing

Call for Contributors

Do you have cases, images, or other information to share? The Neurology Hub welcomes submissions from clinicians and researchers at all levels.

Contribute Here